The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment

Research output: Contribution to journalReview articlepeer-review

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.

Original languageEnglish
Pages (from-to)92-97
Number of pages6
JournalCritical Reviews in Oncology/Hematology
Volume122
DOIs
Publication statusPublished - Feb 2018

Keywords

  • Female
  • Humans
  • Papillomaviridae/immunology
  • Papillomavirus Infections/prevention & control
  • Papillomavirus Vaccines/administration & dosage
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Uterine Cervical Neoplasms/prevention & control
  • Vaccination/statistics & numerical data

Fingerprint Dive into the research topics of 'The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment'. Together they form a unique fingerprint.

Cite this